Cancer Science

In this Issue
pp. i-i(1)

Insulin resistance and cancer: Epidemiological evidence
pp. 1073-1079(7)
Authors: Tsugane, Shoichiro; Inoue, Manami

Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells
pp. 1080-1088(9)
Authors: Schlaeth, Martin; Berger, Sven; Derer, Stefanie; Klausz, Katja; Lohse, Stefan; Dechant, Michael; Lazar, Greg A.; Schneider-Merck, Tanja; Peipp, Matthias; Valerius, Thomas

Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
pp. 1089-1092(4)
Authors: Ichinohasama, Ryo; Oji, Yusuke; Yokoyama, Hisayuki; Takeuchi, Kengo; Fujiwara, Tohru; Ishizawa, Kenichi; Taniguchi, Osamu; Tsuboi, Akihiro; Oka, Yoshihiro; Sugiyama, Haruo

Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens
pp. 1093-1098(6)
Authors: Shimizu, Takeshi; Fan, Yang; Yamana, Daisuke; Miura, Takuya; Nanashima, Naoki; Yamada, Toshiyuki; Tsuchida, Shigeki

Dynamic alteration of protein expression profiles during neoplastic transformation of rat hepatic oval-like cells
pp. 1099-1107(9)
Authors: Li, Xuefei; Li, Yan; Kang, Xiaonan; Guo, Kun; Li, Haiyu; Gao, Dongmei; Sun, Lu; Liu, Yinkun

TGF-β1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation
pp. 1108-1116(9)
Authors: Wang, Shouli; Guo, Lingchuan; Dong, Liang; Guo, Lingling; Li, Shigang; Zhang, Jiajia; Sun, Maomin

Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down-regulated stroma-derived VEGF expression in the bone marrow milieu
pp. 1117-1124(8)
Authors: Zhang, Lu; Hu, Yu; Sun, Chun-yan; Li, Jiang; Guo, Tao; Huang, Jing; Chu, Zhang-bo

Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions
pp. 1125-1132(8)
Authors: Haga, Naomi; Saito, Sakae; Tsukumo, Yoshinori; Sakurai, Junko; Furuno, Aki; Tsuruo, Takashi; Tomida, Akihiro

Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast
pp. 1133-1140(8)
Authors: Kimura, Fuyo; Iwaya, Keiichi; Kawaguchi, Tokuichi; Kaise, Hiroshi; Yamada, Kimito; Mukai, Kiyoshi; Matsubara, Osamu; Ikeda, Norihiko; Kohno, Norio

Subcellular distribution of S100A4 and its transcriptional regulation under hypoxic conditions in gastric cancer cell line BGC823
pp. 1141-1146(6)
Authors: Zhang, Ruixiu; Fu, Hao; Chen, Danqi; Hua, Jun; Hu, Yanping; Sun, Kailai; Sun, Xiuju

Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells
pp. 1147-1155(9)
Authors: Kurotsuchi, Ai; Murakumo, Yoshiki; Jijiwa, Mayumi; Kurokawa, Kei; Itoh, Yasutomo; Kodama, Yoshinori; Kato, Takuya; Enomoto, Atsushi; Asai, Naoya; Terasaki, Hiroko; Takahashi, Masahide

Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2-β-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells
pp. 1156-1162(7)
Authors: Zhu, Hongxia; Zhang, Guo; Wang, Yan; Xu, Ninghong; He, Shun; Zhang, Wei; Chen, Meigui; Liu, Mei; Quan, Lanping; Bai, Jingfeng; Xu, Ningzhi

Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin
pp. 1163-1169(7)
Authors: Suzuki, Kazushi; Kokuryo, Toshio; Senga, Takeshi; Yokoyama, Yukihiro; Nagino, Masato; Hamaguchi, Michinari

Pigpen, a nuclear coiled body component protein, is involved in angiogenesis
pp. 1170-1176(7)
Authors: Yoshida, Tomoko; Sato, Yasufumi; Morita, Ikuo; Abe, Mayumi

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin
pp. 1177-1185(9)
Authors: Shiota, Masaki; Yokomizo, Akira; Kashiwagi, Eiji; Tada, Yasuhiro; Inokuchi, Junichi; Tatsugami, Katsunori; Kuroiwa, Kentaro; Uchiumi, Takeshi; Seki, Narihito; Naito, Seiji

Hyperthermia-associated carboplatin resistance: Differential role of p53, HSF1 and Hsp70 in hepatoma cells
pp. 1186-1193(8)
Authors: Sharma, Aanchal; Meena, Avtar Singh; Bhat, Manoj Kumar

Clinical study of asbestos-related lung cancer in Japan with special reference to occupational history
pp. 1194-1198(5)
Authors: Kishimoto, Takumi; Gemba, Kenichi; Fujimoto, Nobukazu; Onishi, Kazuo; Usami, Ikuji; Mizuhashi, Keiichi; Kimura, Kiyonobu

First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors
pp. 1199-1203(5)
Authors: Kim, Tae Min; Kim, Ki Hwan; Lee, Min Joung; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Chul Woo; Kim, Il Han; Khwarg, Sang In; Heo, Dae Seog

Aurora A selective inhibitor MLN8237 suppresses the growth and survival of HTLV-1-infected T-cells in vitro
pp. 1204-1211(8)
Authors: Tomita, Mariko; Mori, Naoki

Mechanism of antitumor effect of a novel bFGF binding peptide on human colon cancer cells
pp. 1212-1218(7)
Authors: Wang, Cong; Lin, Shaoqiang; Nie, Yanfang; Jia, Xinglong; Wang, Jing; Xiao, Jian; Wu, Jianzhang; Li, Xiaokun; Wu, Xiaoping

Combination of vesicular stomatitis virus matrix protein gene therapy with low-dose cisplatin improves therapeutic efficacy against murine melonoma
pp. 1219-1225(7)
Authors: Luo, Shan; Chen, Ping; Luo, Zi-chao; Zhang, Ping; Sun, Ping; Shi, Wei; Li, Zhi-yong; Zhang, Xiao-long; Wang, Li-qiang; Chen, Xin; Wei, Yu-quan; Wen, Yan-jun

Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis
pp. 1226-1233(8)
Authors: Li, Wei; Xie, Li; Chen, Zheng; Zhu, Yi; Sun, Yujie; Miao, Yi; Xu, Zekuan; Han, Xiao

Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan
pp. 1234-1240(7)
Authors: Kawase, Takakazu; Matsuo, Keitaro; Suzuki, Takeshi; Hirose, Kaoru; Hosono, Satoyo; Watanabe, Miki; Inagaki, Masaki; Iwata, Hiroji; Tanaka, Hideo; Tajima, Kazuo

Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan
pp. 1241-1246(6)
Authors: Shin, Hai-Rim; Boniol, Mathieu; Joubert, Clementine; Hery, Clarisse; Haukka, Jari; Autier, Philippe; Nishino, Yoshikazu; Sobue, Tomotaka; Chen, Chien-Jen; You, San-Lin; Ahn, Sei Hyun; Jung, Kyu Won; Law, Stephen Chun-Key; Mang, Oscar; Chia, Kee-Seng

BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin
pp. 1247-1254(8)
Authors: Shim, Hyun Jeong; Yun, Joo Young; Hwang, Jun Eul; Bae, Woo Kyun; Cho, Sang Hee; Lee, Ji Hee; Kim, Hee Nam; Shin, Min Ho; Kweon, Sun Seog; Lee, Jae Hyuk; Kim, Hyeoung Joon; Chung, Ik Joo

Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancer
pp. 1255-1260(6)
Authors: Qiu, Haifeng; Zhu, Jiezhi; Yuan, Cunzhong; Yan, Shi; Yang, Qifeng; Kong, Beihua

Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer
pp. 1261-1269(9)
Authors: Tada, Motohisa; Kanai, Fumihiko; Tanaka, Yasuo; Sanada, Masashi; Nannya, Yasuhito; Tateishi, Keisuke; Ohta, Miki; Asaoka, Yoshinari; Seto, Motoko; Imazeki, Fumio; Yoshida, Haruhiko; Ogawa, Seishi; Yokosuka, Osamu; Omata, Masao

Pleomorphic phenotypes of gastrointestinal stromal tumors at metastatic sites with or without imatinib treatment
pp. 1270-1278(9)
Authors: Sakamoto, Kazuha; Sakurai, Shinji; Kanda, Tatsuo; Sakuma, Yuji; Hishima, Tsunekazu; Hironaka, Mitsugu; Bamba, Takeo; Keira, Yoshiko; Takano, Yasuo; Niki, Toshiro; Hasegawa, Tadashi; Hirota, Seiichi

Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
pp. 1279-1285(7)
Authors: Wang, Yang; Dong, Qianze; Zhang, Qingfu; Li, Zixuan; Wang, Enhua; Qiu, Xueshan

Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer
pp. 1286-1291(6)
Authors: Nakajima, Takako Eguchi; Yamada, Yasuhide; Hamano, Tetsutaro; Furuta, Koh; Matsuda, Takahisa; Fujita, Shin; Kato, Ken; Hamaguchi, Tetsuya; Shimada, Yasuhiro

Expression of NDRG2 in esophageal squamous cell carcinoma
pp. 1292-1299(8)
Authors: Shi, Hai; Li, Nanlin; Li, Shujun; Chen, Changsheng; Wang, Weizhong; Xu, Chunsheng; Zhang, Jian; Jin, Haifeng; Zhang, Hongwei; Zhao, Huadong; Song, Wenjie; Feng, Quanxin; Feng, Xiangying; Shen, Xin; Yao, Libo; Zhao, Qingchuan

Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer
pp. 1300-1308(9)
Authors: Szarvas, Tibor; Becker, Markus; vom Dorp, Frank; Gethmann, Carolin; Tötsch, Martin; Bánkfalvi, Ágnes; Schmid, Kurt W.; Romics, Imre; Rübben, Herbert; Ergün, Süleyman

Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate
pp. 1309-1313(5)
Authors: Niitsu, Nozomi; Okamoto, Masataka; Nakamine, Hirokazu; Hirano, Masami

Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection
pp. 1314-1319(6)
Authors: Huang, Hua; Zhang, Xiao-Fei; Zhou, Hai-Jun; Xue, Yu-Hua; Dong, Qiong-Zhu; Ye, Qing-Hai; Qin, Lun-Xiu

DJ-1: A novel independent prognostic marker for survival in glottic squamous cell carcinoma
pp. 1320-1325(6)
Authors: Zhu, Xiao-Lin; Wang, Zhang-Feng; Lei, Wen-Bin; Zhuang, Hui-Wen; Jiang, Hong-Yan; Wen, Wei-Ping

Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma
pp. 1326-1330(5)
Authors: Nakai, Reiko; Maniwa, Yoshimasa; Tanaka, Yugo; Nishio, Wataru; Yoshimura, Masahiro; Okita, Yutaka; Ohbayashi, Chiho; Satoh, Naoyuki; Ogita, Hisakazu; Takai, Yoshimi; Hayashi, Yoshitake